
ALT RMST estimates in the intensive and standard systolic BP target arms in SPRINT. The 4-year RMST, or average MACE-free days in 4 years, in the intensive systolic BP group is 1409 days (pinkshaded area), compared to 1394 average MACE-free days in 4 years in the standard SBP group (blue shaded area; purple where the two overlap). The 4-year RMST difference between the intensive and standard systolic BP groups, a measure of treatment effect, is 15 days (95% CI: 6 to 25 days; p=0.002). This measure of treatment effect has the following interpretation: on average, intensive BP control delays MACE by 15 days over 4 years compared to standard BP control. The RMST difference also has a geometric interpretation as the area between two survival curves.






























